CKAP4 can be employed as a biomarker for pancreatic ductal adenocarcinoma diagnosis, staging, and targeted treatment, according to a study of patient blood samples (He et al., 2018b). The gene discussed is CKAP4; the disease is pancreatic ductal adenocarcinoma.